Overflow incontinence (occurs in chronic retention)
As the symptoms are common and non-specific, LUTS is not necessarily a reason to suspect prostate cancer. Large studies of patients have also failed to show any correlation between lower urinary tract symptoms and a specific diagnosis.
Placement of a temporary prostatic stent as a differential diagnosis test can help identify whether LUTS symptoms are directly related to obstruction of the prostate or to other factors worth investigation.
ICD 9 CM
600.00 Hypertrophy (benign) of prostate w/o urinary obstruction and other lower urinary tract symptoms (LUTS)
600.01 Hypertrophy (benign) of prostate with urinary obstruction and other LUTS
600.20 Benign localized hyperplasia of prostate w/o urinary obstruction and other LUTS
600.21 Benign localized hyperplasia of prostate with urinary obstruction and other LUTS
600.90 Hyperplasia of prostate, unspecified, w/o urinary obstruction and other LUTS
600.91 Hyperplasia of prostate, unspecified, with urinary obstruction and other LUTS
A number of techniques to destroy part or all of the prostate have been developed. First line of treatment is medical, which includes alpha-1 blockade and antiandrogens. If the medical treatment fails, surgical techniques are done. Techniques include:
The best nowadays is TURP: trans-urethral removal of the prostate.
Other treatments include lifestyle advice. Although surgical treatment is generally reserved for men who have failed or are unable to tolerate drug treatment, or for those who have developed complications
Prevalence increases with age. The prevalence of nocturia in older men is about 78%. Older men have a higher incidence of LUTS than older women.